Knoll Capital Management, LLC
MIAMI, FL · CIK 1325083 · 13F filing filed 2023-05-15
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Others nearbyMiami, FL
$59.8m
reported value
+35.0% vs Q4 2022
24positions
78.6%in top 10
6 new
6 added
0 reduced
3 sold out
vs Q4 2022
Options: 2 call positions ($5.1m notional), 0 put positions (— notional) – listed below, not included above.
Holdings, Q1 2023
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| ALDEYRA THERAPEUTICS INC ALDX | $20.5m34.32% | Added +119.1k |
| BIOHAVEN PHARMACTL HLDG CO L BHVN | $6.2m10.29% | Unchanged |
| VERONA PHARMA PLC VRNA | $4.0m6.72% | Added +104.6k |
| VANECK ETF TRUST GDX | $3.0m4.97% | Unchanged |
| ENTERA BIO LTD ENTX | $2.9m4.82% | Unchanged |
| APPLIED THERAPEUTICS INC APLT | $2.8m4.68% | Added +1.0m |
| GLOBAL X FDS SIL | $2.8m4.61% | Unchanged |
| VANECK ETF TRUST GDXJ | $2.1m3.51% | Unchanged |
| OCULAR THERAPEUTIX INC OCUL | $1.5m2.51% | New |
| OSISKO GOLD ROYALTIES LTD COM | $1.3m2.13% | Added +165.0k |
| THERMO FISHER SCIENTIFIC INC TMO | $1.2m2.03% | Unchanged |
| BOOZ ALLEN HAMILTON HLDG COR BAH | $1.2m2.01% | Unchanged |
| VISA INC V | $1.1m1.83% | Unchanged |
| CVS HEALTH CORP CVS | $1.1m1.80% | Unchanged |
| SILVERCREST METALS INC SIL | $1.0m1.75% | New |
| OMEGA THERAPEUTICS INC COMMON STOCK | $1.0m1.74% | New |
| SEABRIDGE GOLD INC COM | $1.0m1.73% | Added +39.0k |
| FRANCO NEV CORP FNV | $1.0m1.71% | New |
| ALTRIA GROUP INC MO | $1.0m1.69% | Unchanged |
| NORTHROP GRUMMAN CORP NOC | $999.6k1.67% | New |
| Orgenesis, Inc. COM | $749.0k1.25% | Unchanged |
| ALTIMMUNE INC ALT | $733.7k1.23% | Unchanged |
| OPUS GENETICS INC IRD | $375.0k0.63% | New |
| HOOKIPA PHARMA INC COM | $220.8k0.37% | Added +250.0k |
Sold out since Q4 2022
| Security | Value then |
|---|---|
| AVADEL PHARMACEUTICALS PLC | $1.1m150.0k shares |
| BLACKSTONE GROUP L P BX | $741.9k10.0k shares |
| Anavex Life Sciences Corp | $98.9k10.7k shares |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| AVADEL PHARMACEUTICALS PLC Call | $4.6m500.0k shares | New |
| OCULAR THERAPEUTIX INC OCUL · Call | $504.9k95.8k shares | New |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| ELICIO THERAPEUTICS INC ELTX · 13G · filed 2026-07-08 | 5.3%≈ $4.7m |